GPT-5 Cracked a 3-Year Immunology Mystery in Days
GPT-5 Pro helped immunologist Derya Unutmaz solve a 3-year-old mystery about T cell behavior — with huge implications for cancer and autoimmune disease research.
GPT-5 Pro helped immunologist Derya Unutmaz solve a 3-year-old mystery about T cell behavior — with huge implications for cancer and autoimmune disease research.
OpenAI’s Daybreak launch brings Codex Security and GPT-5.5-Cyber to enterprise teams. Here’s what these AI-powered vulnerability tools actually do and who needs them.
OpenAI’s Patch the Planet initiative uses AI to help open-source maintainers find and fix vulnerabilities. Here’s what it does and why it matters.
OpenAI launches LifeSciBench, an expert-authored benchmark testing AI on real-world life science research tasks. Here’s what it measures and why it matters.
OpenAI and Molecule.one built a near-autonomous AI chemist using GPT-5 that improved a key medicinal chemistry reaction. Here’s what that actually means.
OpenAI’s reasoning model helped physicians crack 18 previously unsolved rare genetic disease cases in children. Here’s what happened and why it matters.
OpenAI’s GPT-4.5 brings stronger health reasoning to ChatGPT, with physician-informed evaluations and clearer medical communication. Here’s what changed.
OpenAI’s new usage analytics and spend controls for ChatGPT Enterprise give IT teams real budget visibility. Here’s what changed and why it matters now.
OpenAI’s Deployment Simulation uses real conversation data to predict model behavior before release. Here’s what it does, why it matters, and who benefits.
OpenAI launches its Partner Network with $150M in investment to accelerate enterprise AI adoption globally. Here’s what it means for businesses and partners.
Preply is using OpenAI to generate AI-powered lesson summaries and personalized feedback — here’s what it means for the future of language learning.
OpenAI launches three Academy courses teaching practical AI skills, repeatable workflows, and agent use. Here’s what’s in them and who they’re really for.